Ono et al. 1988 J. Biol. Chem. 263(14): 6927-6932. |
Martin, P. 1995, Helv. Chim. Acta 78, 486-504. |
Orkin et al. Dec. 7, 1995 "Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy". |
Gura, T. 1995 Science 270: 575-577. |
Infectious Disease Weekly (Oct. 23, 1995), Charles W. Henderson (Publ.). |
Boyce et al. 1996 Neurosci. Res. Commun. 18(3): 195-201. |
Dean et al. (Mar.) 1995 Proc. Annu. Meet. Assoc. Cancer Res. 36: 413, Abstract 2460. |
PR Newswire, Aug. 1, 1996 p. 0801LATH014, (PR Newswire Assoc., Inc.). |
Ahmad et al., "Antisense Expression of Protein Kinase C.alpha. Inhibits the Growth and Tumorigenicity of Human Glioblastoma Cells", Neurosurg., 35:904-908 (1994). |
Bacher, N. et al., "Isolation and Characterization of PKC-L, A New Member of the Protein Kinase C-Related Gene Family Specifically Expressed in Lung, Skin, and Heart", Mol. Cell. Biol. 11:126-133 (1991). |
Ballester, R. and Rosen, O., "Fate of Immunoprecipitable Protein Kinase C in GH.sub.3 Cells Treated with Phorbol 12-Myristate 13-Acetate", J. Biol. Chem., 260, 260(28):15194-15199 (1985). |
Baxter, et al., "PKC-episilon is involved in granulocyte-macrophage colong-stimulating factor signal transduction: Evidence from microphysiometry and antisense oligonucleotide experiments", Biochemistry, 31: 10950-10954 (1992). |
Berkowitz, P.T. et al., "Synthesis of 1,2-Dihydro-1-(2deoxy-.beta.-D-Erythro-pentafuranosyl)-2-Oxopyrazine 4-oxide, a potent analog of deoxyuridine", J. Med. Chem., 16: 183-184 (1985). |
Borek, C. et al., "Long-chain (sphingoid) bases inhibit multistage carcinogenesis in mouse C3H/10T1/2 cells treated with radiation and phorbol 12-myristate 13-acetate", Proc. Natl. Acad. Sci., 88, 1953-1957 (1991). |
Brandt, et al., "District Patters of Expression of Different Protein Kinase CmRNA's in Rat Tissues", Cell., 49:57-63 (1987). |
Coussens et al., "Multiple, Distinct Forms of Bovine and Human Protein Kinase C Suggest Diversity in Cellular Signaling Pathways", Science, 233:859-866 (1986). |
Endo, et al., "Cell Membrane Signaling as Target in Cancer Therapy: Inhibitory Effect of N,N-Dimethyl and N,N,N-Trimethyl Sphingosine Derivatives on In Vitro and In Vivo Growth of Human Tumor Cells in Nude Mice", Cancer Research, 51:1613-1618 (1991). |
Farese, et al., "Antisense DNA downregulates protein kinase C isozymes (beta and alpha) and insulin-stimulated 2-deoxyglucose uptake in rat adipocytes", Antisense Res. Dev., 1 (1): 35-42 (1991). |
Finkenzeller, G., "Sequence of Human Protein Kinase C .alpha.", Nucleic Acids Research, 18:2183 (1990). |
Gescher, A. and Dale, I.L., "Protein Kinase C-A Novel Target for Rational Anti-Cancer Drug Design", Anti-Cancer Drug Design ,4:93-105 (1989). |
Godson, et al., "Inhibition of Expression of Protein Kinase C .alpha. by Antisense cDNA Inhibits Phorbol Ester-Mediated Archidonate Release", The Journal of Biological Chemistry, 268:11946-11950 (1993). |
Hackh's Chemical Dictionary, Grant, et al. (ed.), McGraw-Hill Book Company, New York, p. 312. |
Hegemann, L. and G. Mahrle, Pharmacology of the Skin, H. Mukhtar, ed., pp. 357-368, CRC press, Boca Raton, FL, 1992. |
Hidaka, H. and Hagiwara, M., "Pharmacology of the isoquinoline sulfonamide protein kinase C inhibitors", TIPS, 8:162-164 (1987). |
Maister, Bioworld Today, Apr. 29, 1994, p. 3. |
Kubo, K., et al., "Primary structures of human protein kinase CBI and BII differ only in their C-terminal sequences", Febs Letters, 223(1): 138-142 (1987). |
Krug, E. et al., "Evidence for increased synthesis as well as increased degradation of protein kinase C after treatment of human ostersarcoma cells with phorbol ester", J. of Biological Chemistry, 262(24): 11852-11856 (1987). |
Standaert, et al.,1991, J. Cellular Biochem. (Keystone Symposia on Molecular and Cellular Biology, 18-25 Jan.), Suppl. 15B, p. 26, abstract CA 211. |
Maier, et al., "An oligomer targeted against protein kinase C alpha prevents interleukin-1 alpha induction of cycloxygenase expression in human endothelial cells", Exp. Cell. Res., 205 (1): 52-58 (1993). |
Marcus-Sekura, "Techniques for Using Antisense Oligodeoxyribonucleotides to Study Gene Expression", Analytical Biochemistry, vol. 172, issued 1988, 289-295. |
Nielsen, P.E., et al., "Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted Polyamide", Science, 254: 1497-1500 (1991). |
Nishizuka, Y., "The Molecular Heterogeneity of Protein Kinase C and its Implications for Cellular Regulation", Nature, 334: 661-665 (1988). |
Osada, S. et al., "A phorbol ester receptor/protein kinase, nPKC.eta., a new member of the protein kinase C family predominantly expressed in lung and skin", J. of Biological Chemistry, 265(36): 22434-22440 (1990). |
Parker et al., "The complete primary structure of protein kinase c-the major phorbol ester receptor", Science, 233:853-866 (1986). |
Rothenberg, et al., "Oligodeoxynucleotides as Anti-Sense Inhibitors of Gene Expression: Therapeutic Implications", J. Natl. Cancer Inst., 81(20):1539-1544. |
Sakanou, Youichirou et al., "Protein Kinase C Activity as Marker for Colorectal Cancer" Int. J. Cancer 48: 803-806 (1991). |
Sambrook et al., Molecular Cloning. A Laboratory Manual, Cold Spring Harbor Laboratory Press, 1989, vol. 2, p. 10.59. |
Simons et al., "Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo", Nature 359:67-70 (1992). |
1993 Catalog of Products for DNA Research, Glen Research, Sterling, VA, p. 21. |
Watson, et al., 1987, in Molecular Biology of The Gene, fourth edition, Benjamin/Cummings Publishing Company, Menlo Park, CA p. 241. |
Webster's II New Riverside University Dictionary, Soukkhanov, et al., (eds.) 1984, Houghton Mifflin Company, Boston, MA p. 68. |
Weinstein, I.B., "Cancer Prevention: Recent Progress and Future Opportunities", Cancer Research, 51:5080s-5085s (1991). |
Young, S. et al., "Down-regulation of protein kinase C is due to an increased rate of degradation", Biochem., 244:775-779 (1987). |
Zon, "Oligonucleotide Analogues as Potential Chemotherapeutic Agents", Pharmaceuticals Res., 5:539-549 (1988). |
Kawasaki et al., "Synthesis and Biophysical Studies of 2'-dRIBO-F Modified Oligonucleotides", Conference on Nucleic Acid Therapeutics, Clearwater, FL, Jan., 1991. |